You are here

Article info

Article menu
Original research
Caffeine to prevent intermittent hypoxaemia in late preterm infants: randomised controlled dosage trial

Authors

  • Elizabeth Anne Oliphant Department of Paediatrics: Child and Youth Health, The University of Auckland, Auckland, New Zealand Starship Child Health, Auckland District Health Board, Auckland, New Zealand PubMed articlesGoogle scholar articles
  • Christopher JD McKinlay Department of Paediatrics: Child and Youth Health, The University of Auckland, Auckland, New Zealand Kidz First Neonatal Care, Counties Manukau District Health Board, Auckland, New Zealand PubMed articlesGoogle scholar articles
  • David McNamara Starship Child Health, Auckland District Health Board, Auckland, New Zealand PubMed articlesGoogle scholar articles
  • Alana Cavadino Section of Epidemiology and Biostatistics, The University of Auckland, Auckland, New Zealand PubMed articlesGoogle scholar articles
  • Jane M Alsweiler Department of Paediatrics: Child and Youth Health, The University of Auckland, Auckland, New Zealand Starship Child Health, Auckland District Health Board, Auckland, New Zealand PubMed articlesGoogle scholar articles
  1. Correspondence to Associate Professor Jane M Alsweiler, Department of Paediatrics: Child & Youth Health, The University of Auckland, Auckland, 1142, New Zealand; j.alsweiler{at}auckland.ac.nz
View Full Text

Citation

Oliphant EA, McKinlay CJ, McNamara D, et al
Caffeine to prevent intermittent hypoxaemia in late preterm infants: randomised controlled dosage trial
Archives of Disease in Childhood - Fetal and Neonatal Edition 2023;108:106-113.

Publication history

  • Received February 15, 2022
  • Accepted July 12, 2022
  • First published August 29, 2022.
Online issue publication 
March 15, 2024

Article Versions

  • Supplementary Data

    This web only file has been produced by the BMJ Publishing Group from an electronic file supplied by the author(s) and has not been edited for content.

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Copyright information

© Author(s) (or their employer(s)) 2023. Re-use permitted under CC BY. Published by BMJ. https://creativecommons.org/licenses/by/4.0/This is an open access article distributed in accordance with the Creative Commons Attribution 4.0 Unported (CC BY 4.0) license, which permits others to copy, redistribute, remix, transform and build upon this work for any purpose, provided the original work is properly cited, a link to the licence is given, and indication of whether changes were made. See: https://creativecommons.org/licenses/by/4.0/.